Estrogen receptor status and adjuvant polychemotherapy or antiestrogen therapy in patients with high-risk breast cancer

W. Jonat; H. Maass; M. Braun; G. Winter

doi:10.1007/bf01032614

Estrogen receptor status and adjuvant polychemotherapy or antiestrogen therapy in patients with high-risk breast cancer

Journal of Cancer Research and Clinical Oncology ◽

10.1007/bf01032614 ◽

1984 ◽

Vol 107 (3) ◽

pp. 233-237 ◽

Cited By ~ 1

Author(s):

W. Jonat ◽

H. Maass ◽

M. Braun ◽

G. Winter

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

High Risk ◽

Estrogen Receptor Status ◽

Receptor Status ◽

Antiestrogen Therapy ◽

High Risk Breast Cancer ◽

High Risk Breast ◽

Risk Breast Cancer

Download Full-text

Importance of HER2 and receptor status on the response to adjuvant radiotherapy in high-risk breast cancer — Results from the DBCG82 b&c randomized study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)80243-0 ◽

2006 ◽

Vol 4 (2) ◽

pp. 112

Author(s):

M. Kyndi ◽

Sørensen ◽

H. Knudsen ◽

M. Overgaard ◽

H.M. Nielsen ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Adjuvant Radiotherapy ◽

Randomized Study ◽

Receptor Status ◽

High Risk Breast Cancer ◽

High Risk Breast ◽

Risk Breast Cancer

Download Full-text

Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial

European Journal of Cancer ◽

10.1016/j.ejca.2014.02.022 ◽

2014 ◽

Vol 50 (8) ◽

pp. 1412-1421 ◽

Cited By ~ 17

Author(s):

Ann S. Knoop ◽

Anne-Vibeke Lænkholm ◽

Maj-Britt Jensen ◽

Kirsten V. Nielsen ◽

Jørn Andersen ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

High Risk ◽

Progesterone Receptor ◽

Her2 Status ◽

Ki67 Index ◽

Breast Cancer Patients ◽

High Risk Breast Cancer ◽

High Risk Breast ◽

Risk Breast Cancer

Download Full-text

Adjuvant trastuzumab use in high-risk breast cancer patients may prevent development of contralateral estrogen receptor-negative breast tumors

Medical Hypotheses ◽

10.1016/j.mehy.2005.06.007 ◽

2006 ◽

Vol 66 (5) ◽

pp. 1045-1046 ◽

Cited By ~ 2

Author(s):

Kadri Altundag ◽

Ozden Altundag ◽

Rabiul Islam ◽

Ozlem Gundeslioglu

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

High Risk ◽

Breast Tumors ◽

Breast Cancer Patients ◽

Adjuvant Trastuzumab ◽

High Risk Breast Cancer ◽

High Risk Breast ◽

Estrogen Receptor Negative ◽

Risk Breast Cancer

Download Full-text

Faculty Opinions recommendation of Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1109267.565278 ◽

2008 ◽

Author(s):

Alphonse Taghian ◽

Mohamed Alm El-Din

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

High Risk ◽

Progesterone Receptor ◽

Cooperative Group ◽

Postmastectomy Radiotherapy ◽

Her 2 ◽

High Risk Breast Cancer ◽

High Risk Breast ◽

Risk Breast Cancer

Download Full-text

High-Risk Breast Cancer

10.1007/978-3-642-73718-3 ◽

1989 ◽

Cited By ~ 1

Keyword(s):

Breast Cancer ◽

High Risk ◽

High Risk Breast Cancer ◽

High Risk Breast ◽

Risk Breast Cancer

Download Full-text

Hypofractionated Versus Conventional Fractionated Postmastectomy Radiotherapy for High-Risk Breast Cancer Patients: A Randomized, Phase III, Non-Inferiority, Open-Label Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3247893 ◽

2018 ◽

Author(s):

Shu-Lian Wang ◽

Hui Fang ◽

Yong-Wen Song ◽

Wei-Hua Wang ◽

Chen Hu ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Phase Iii ◽

Breast Cancer Patients ◽

Open Label ◽

Postmastectomy Radiotherapy ◽

Open Label Trial ◽

High Risk Breast Cancer ◽

High Risk Breast ◽

Risk Breast Cancer

Download Full-text

139P Association of baseline neutrophil-lymphocyte and platelet-lymphocyte ratios with disease progression in high-risk breast cancer patients

Annals of Oncology ◽

10.1016/j.annonc.2021.03.153 ◽

2021 ◽

Vol 32 ◽

pp. S81

Author(s):

R. Cahyono ◽

S.L. Anwar ◽

H.Y. Budiman ◽

T. Aryandono ◽

W.A. Harahap

Keyword(s):

Breast Cancer ◽

High Risk ◽

Disease Progression ◽

Cancer Patients ◽

Breast Cancer Patients ◽

High Risk Breast Cancer ◽

High Risk Breast ◽

Risk Breast Cancer

Download Full-text

Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer

The Breast ◽

10.1016/j.breast.2021.04.002 ◽

2021 ◽

Author(s):

Jing Yang ◽

Shu-Nan Qi ◽

Hui Fang ◽

Yong-Wen Song ◽

Jing Jin ◽

...

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Cost Effectiveness ◽

High Risk ◽

Fractionated Radiation Therapy ◽

Hypofractionated Radiation ◽

High Risk Breast Cancer ◽

High Risk Breast ◽

Risk Breast Cancer ◽

Fractionated Radiation

Download Full-text

2 Postmastectomy Radiotherapy Use in Elderly Patients with High-Risk Breast Cancer

Radiotherapy and Oncology ◽

10.1016/s0167-8140(05)80163-x ◽

2005 ◽

Vol 76 ◽

pp. S1

Author(s):

J. Lee ◽

P. Truong ◽

H. Kadee ◽

C. Spees ◽

I. Olivotto

Keyword(s):

Breast Cancer ◽

High Risk ◽

Elderly Patients ◽

Postmastectomy Radiotherapy ◽

High Risk Breast Cancer ◽

High Risk Breast ◽

Risk Breast Cancer

Download Full-text

Variation in risk management choice for women with different high risk breast cancer gene mutations in a single UK centre Wattoo G, Morgan J, Dyer C, Wyld L, Langdale B.

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2020.11.147 ◽

2021 ◽

Vol 47 (2) ◽

pp. e1

Author(s):

Ghulam Wattoo

Keyword(s):

Breast Cancer ◽

Risk Management ◽

High Risk ◽

Gene Mutations ◽

Cancer Gene ◽

High Risk Breast Cancer ◽

High Risk Breast ◽

Risk Breast Cancer ◽

Management Choice ◽

Breast Cancer Gene

Download Full-text